Home Medicine Commutability assessment of reference materials for the enumeration of lymphocyte subsets
Article
Licensed
Unlicensed Requires Authentication

Commutability assessment of reference materials for the enumeration of lymphocyte subsets

  • Chenbin Li ORCID logo , Mingting Peng EMAIL logo , Dongsheng Xu , Hong Lu , Wenbin Zhou , Yanhong Liu , Xiuli Liu and Wenxiang Chen EMAIL logo
Published/Copyright: December 20, 2018

Abstract

Background

Flow cytometric enumeration of lymphocyte subsets in peripheral blood can provide important information about immune status. Commutable reference materials (RM) are crucial for maintaining accurate and comparable measurement results over time and space. Commutability assessment of RMs for lymphocyte subsets enumeration has not been reported elsewhere.

Methods

Lymphocyte subsets were measured in triplicate on 56 patient samples and eight RMs using two measuring systems commonly used in laboratories (FACS Canto II and Cytomics FC500). The first step was to determine the suitability of RMs and comparability of different systems with patient samples. After the requirements of suitability and comparability were met, the second step was to assess commutability following regression approach and difference in bias approach.

Results

Two RMs were not measurable on FC500 system for CD3-CD16/56+ and CD3-CD19+ percentages. The results of comparability showed no significant difference in the two systems. Eight RMs for CD3+CD4+ cell count, six RMs for CD3+ and CD3+CD8+ percentages, five RMs for CD3-CD16/56+ percentage, and three RMs for CD3-CD19+ percentage were commutable using the two approaches. For CD3+, CD3+CD8+ and CD3-CD19+ percentages, the results of regression approach showed that one RM was non-commutable for each parameter, while the other approach showed that the RM was commutable.

Conclusions

The suitability of RM and comparability of different measuring systems are prerequisites for assessing commutability. This study indicated that different approaches led to different results. The difference in bias approach is recommended for criteria relating to medical requirements and performance characteristics of measuring systems in use.

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: National Special Project of Science and Technology Basic Work of Ministry of Science and Technology of China, Grant Number: 2013FY113800.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Levering WH, van Wieringen WN, Kraan J, van Beers WA, Sintnicolaas K, van Rhenen DJ, et al. Flow cytometric lymphocyte subset enumeration: 10 years of external quality assessment in the Benelux countries. Cytometry B Clin Cytom 2008;74:79–90.10.1002/cyto.b.20370Search in Google Scholar PubMed

2. Deprez L, Toussaint B, Zegers I, Schimmel H, Grote-Koska D, Klauke R, et al. Commutability assessment of candidate reference materials for pancreatic alpha-amylase. Clin Chem 2018;64:1193–202.10.1373/clinchem.2018.289744Search in Google Scholar PubMed

3. Carobene A, Ceriotti F, Infusino I, Frusciante E, Panteghini M. Evaluation of the impact of standardization process on the quality of serum creatinine determination in Italian laboratories. Clin Chim Acta 2014;427:100–6.10.1016/j.cca.2013.10.001Search in Google Scholar PubMed

4. Korzun WJ, Nilsson G, Bachmann LM, Myers GL, Sakurabayashi I, Nakajima K, et al. Difference in bias approach for commutability assessment: application to frozen pools of human serum measured by 8 direct methods for HDL and LDL cholesterol. Clin Chem 2015;61:1107–13.10.1373/clinchem.2015.240861Search in Google Scholar PubMed

5. Bjerke M, Andreasson U, Kuhlmann J, Portelius E, Pannee J, Lewczuk P, et al. Assessing the commutability of reference material formats for the harmonization of amyloid-beta measurements. Clin Chem Lab Med 2016;54:1177–91.10.1515/cclm-2015-0733Search in Google Scholar PubMed

6. Jansen R, Jassam N, Thomas A, Perich C, Fernandez-Calle P, Faria AP, et al. A category 1 EQA scheme for comparison of laboratory performance and method performance: an international pilot study in the framework of the Calibration 2000 project. Clin Chim Acta 2014;432:90–8.10.1016/j.cca.2013.11.003Search in Google Scholar PubMed

7. Robijns K, Boone NW, Jansen RT, Kuypers AW, Neef C, Touw DJ. Commutability of proficiency testing material containing tobramycin: a study within the framework of the Dutch Calibration 2.000 project. Clin Chem Lab Med 2017;55:212–7.10.1515/cclm-2015-1254Search in Google Scholar PubMed

8. Ding T, Bergeron M, Seely P, Yang X, Diallo TO, Plews M, et al. Compatibility of stabilized whole blood products with CD4 technologies and their suitability for quality assessment programs. PLoS One 2014;9:e103391.10.1371/journal.pone.0103391Search in Google Scholar PubMed PubMed Central

9. CLSI. Characterization and Qualification of Commutable Reference Materials for Laboratory Medicine; Approved Guideline. CLSI document EP30-A. Wayne, PA: Clinical and Laboratory Standards Institute, 2010.Search in Google Scholar

10. Nilsson G, Budd JR, Greenberg N, Delatour V, Rej R, Panteghini M, et al. IFCC Working Group Recommendations for Assessing Commutability Part 2: using the difference in bias between a reference material and clinical samples. Clin Chem 2018;64:455–64.10.1373/clinchem.2017.277541Search in Google Scholar PubMed PubMed Central

11. Glencross D, Scott LE, Jani IV, Barnett D, Janossy G. CD45-assisted PanLeucogating for accurate, cost-effective dual-platform CD4+ T-cell enumeration. Cytometry 2002;50:69–77.10.1002/cyto.10068Search in Google Scholar PubMed

12. CLSI. Measurement procedure comparison and bias estimation using patient samples; Approved Guideline – Third Edition. CLSI document EP09-A3. Wayne, PA: Clinical Laboratory Standards Institute, 2013.Search in Google Scholar

13. Giavarina D. Understanding Bland Altman analysis. Biochem Med (Zagreb) 2015;25:141–51.10.11613/BM.2015.015Search in Google Scholar PubMed PubMed Central

14. U.S. National Institutes of Health. Guidelines for the use of antiretroviral agents in adults and adolescents living with HIV. Available at: https://aidsinfo.nih.gov/guidelines/html/1/adult-and-adolescent-arv/458/plasma-hiv-1-rna--viral-load--and-cd4-count-monitoring. Accessed: Aug 14th.Search in Google Scholar

15. Tosato F, Bernardi D, Sanzari MC, Pantano G, Plebani M. Biological variability of lymphocyte subsets of human adults’ blood. Clin Chim Acta 2013;424:159–63.10.1016/j.cca.2013.06.001Search in Google Scholar PubMed

16. Miller WG, Myers GL. Commutability still matters. Clin Chem 2013;59:1291–3.10.1373/clinchem.2013.208785Search in Google Scholar PubMed

17. Miller WG. The role of proficiency testing in achieving standardization and harmonization between laboratories. Clin Biochem 2009;42:232–5.10.1016/j.clinbiochem.2008.09.004Search in Google Scholar PubMed

18. Miller WG, Jones GR, Horowitz GL, Weykamp C. Proficiency testing/external quality assessment: current challenges and future directions. Clin Chem 2011;57:1670–80.10.1373/clinchem.2011.168641Search in Google Scholar PubMed

19. World Health Organization. WHO Expert Committee on Biological Standardization: Sixty-First Report. Available at: http://www.who.int/biologicals/expert_committee/TRS_978_61st_report.pdf. Accessed: 14 Aug 2018.Search in Google Scholar

20. BIPM. JCTLM-WG1 Quality Manual. Available at: https://www.bipm.org/en/committees/jc/jctlm/jctlm-wg1/wg1_quality-manual.html. Accessed: 23 Aug 2018.Search in Google Scholar

21. UK NEQAS for Leucocyte Immunophenotyping. Immune Monitoring (Alternative Technologies). Available at: http://www.ukneqasli.co.uk/eqa-pt-programmes/flow-cytometry-programmes/immune-monitoring-alternative-technologies/. Accessed: 14 Aug 2018.Search in Google Scholar

22. Hayden RT, Preiksaitis J, Tong Y, Pang X, Sun Y, Tang L, et al. Commutability of the First World Health Organization International Standard for human cytomegalovirus. J Clin Microbiol 2015;53:3325–33.10.1128/JCM.01495-15Search in Google Scholar PubMed PubMed Central

23. Carobene A, Guerra E, Ceriotti F. A mechanism-based way to evaluate commutability of control materials for enzymatic measurements. The example of gamma-glutamyltransferase. Clin Chim Acta 2013;424:153–8.10.1016/j.cca.2013.06.012Search in Google Scholar PubMed

24. Zhang S, Zeng J, Zhang C, Li Y, Zhao H, Cheng F, et al. Commutability of possible external quality assessment materials for cardiac troponin measurement. PLoS One 2014;9:e102046.10.1371/journal.pone.0102046Search in Google Scholar PubMed PubMed Central

25. Ceriotti F, Fernandez-Calle P, Klee GG, Nordin G, Sandberg S, Streichert T, et al. Criteria for assigning laboratory measurands to models for analytical performance specifications defined in the 1st EFLM Strategic Conference. Clin Chem Lab Med 2017;55:189–94.10.1515/cclm-2017-0772Search in Google Scholar PubMed

26. Aarsand AK, Roraas T, Fernandez-Calle P, Ricos C, Diaz-Garzon J, Jonker N, et al. The Biological Variation Data Critical Appraisal Checklist: A Standard for Evaluating Studies on Biological Variation. Clin Chem 2018;64:501–14.10.1373/clinchem.2017.281808Search in Google Scholar PubMed

27. Bratescu A, Teodorescu M. Circannual variations in the B cell/T cell ratio in normal human peripheral blood. J Allergy Clin Immunol 1981;68:273–80.10.1016/0091-6749(81)90151-2Search in Google Scholar

28. Abo T, Miller CA, Cloud GA, Blach CM. Annual stability in the levels of lymphocyte subpopulations identified by monoclonal antibodies in blood of healthy individuals. J Clin Immunol 1985;5:13–20.10.1007/BF00915163Search in Google Scholar PubMed

29. Ritchie AW, Oswald I, Micklem HS, Boyd JE, Elton RA, Jazwinska E, et al. Circadian variation of lymphocyte subpopulations: a study with monoclonal antibodies. Br Med J (Clin Res Ed) 1983;286:1773–5.10.1136/bmj.286.6380.1773Search in Google Scholar PubMed PubMed Central

30. Backteman K, Ledent E, Berlin G, Ernerudh J. A rapid and reliable flow cytometric routine method for counting leucocytes in leucocyte-depleted platelet concentrates. Vox Sang 2002;83:29–34.10.1046/j.1423-0410.2002.00196.xSearch in Google Scholar PubMed

31. Backteman K, Ernerudh J. Biological and methodological variation of lymphocyte subsets in blood of human adults. J Immunol Methods 2007;322:20–7.10.1016/j.jim.2007.01.021Search in Google Scholar PubMed

32. German Reference Institute for Bioanalytics Surveys Immunphenotyping (flow cytometry) 2018. Available at: https://www.rfb.bio/cgi/results?rv_type=IS&rvTypeForDetails=IS&year=2018&rv_num=1&analyte=all&searchType=rv_type. Accessed: 24 Jul 2018.Search in Google Scholar


Supplementary Material

The online version of this article offers supplementary material (https://doi.org/10.1515/cclm-2018-0915).


Received: 2018-08-24
Accepted: 2018-11-19
Published Online: 2018-12-20
Published in Print: 2019-04-24

©2019 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. Cardiac biomarkers – 2019
  4. Reviews
  5. Current understanding and future directions in the application of TIMP-2 and IGFBP7 in AKI clinical practice
  6. Serum cytokines, adipokines and ferritin for non-invasive assessment of liver fibrosis in chronic liver disease: a systematic review
  7. Opinion Papers
  8. Detection capability of quantitative faecal immunochemical tests for haemoglobin (FIT) and reporting of low faecal haemoglobin concentrations
  9. Should phosphatidylethanol be currently analysed using whole blood, dried blood spots or both?
  10. IFCC Papers
  11. High sensitivity, contemporary and point-of-care cardiac troponin assays: educational aids developed by the IFCC Committee on Clinical Application of Cardiac Bio-Markers
  12. Cardiac troponin and natriuretic peptide analytical interferences from hemolysis and biotin: educational aids from the IFCC Committee on Cardiac Biomarkers (IFCC C-CB)
  13. Genetics and Molecular Diagnostics
  14. Droplet digital PCR for the simultaneous analysis of minimal residual disease and hematopoietic chimerism after allogeneic cell transplantation
  15. General Clinical Chemistry and Laboratory Medicine
  16. Commutable whole blood reference materials for hemoglobin A1c validated on multiple clinical analyzers
  17. When results matter: reliable creatinine concentrations in hyperbilirubinemia patients
  18. Mass spectrometry based analytical quality assessment of serum and plasma specimens with patterns of endo- and exogenous peptides
  19. Association of serum sphingomyelin profile with clinical outcomes in patients with lower respiratory tract infections: results of an observational, prospective 6-year follow-up study
  20. Effect of an activated charcoal product (DOAC Stop™) intended for extracting DOACs on various other APTT-prolonging anticoagulants
  21. Hematology and Coagulation
  22. Commutability assessment of reference materials for the enumeration of lymphocyte subsets
  23. Circulating platelet-neutrophil aggregates as risk factor for deep venous thrombosis
  24. Reference Values and Biological Variations
  25. A comparison of complete blood count reference intervals in healthy elderly vs. younger Korean adults: a large population study
  26. Indirect determination of hematology reference intervals in adult patients on Beckman Coulter UniCell DxH 800 and Abbott CELL-DYN Sapphire devices
  27. Cancer Diagnostics
  28. Large platelet size is associated with poor outcome in patients with metastatic pancreatic cancer
  29. Cardiovascular Diseases
  30. Sample matrix and high-sensitivity cardiac troponin I assays
  31. Preoperative proteinuria and clinical outcomes in type B aortic dissection after thoracic endovascular aortic repair
  32. Infectious Diseases
  33. The rational specimen for the quantitative detection of Epstein-Barr virus DNA load
  34. Letters to the Editor
  35. Letter to the Editor on article Dimech W, Karakaltsas M, Vincini G. Comparison of four methods of establishing control limits for monitoring quality controls in infectious disease serology testing. Clin Chem Lab Med 2018;56:1970–8
  36. Counterpoint to the Letter to the Editor by Badrick and Parvin in regard to Comparison of four methods of establishing control limits for monitoring quality controls in infectious disease serology testing
  37. Is creatine kinase an ideal biomarker in rhabdomyolysis? Reply to Lippi et al.: Diagnostic biomarkers of muscle injury and exertional rhabdomyolysis (https://doi.org/10.1515/cclm-2018-0656)
  38. Blood neuron cell-derived microparticles as potential biomarkers in Alzheimer’s disease
  39. A fast, nondestructive, low-cost method for the determination of hematocrit of dried blood spots using image analysis
  40. Association of fibroblast growth factor 21 plasma levels with neonatal sepsis: preliminary results
  41. Impact of continuous renal replacement therapy (CRRT) and other extracorporeal support techniques on procalcitonin guided antibiotic therapy in critically ill patients with septic shock
  42. Determining the cutoff value of the APTT mixing test for factor VIII inhibitor
  43. Determining the cut-off value of the APTT mixing test for factor VIII inhibitor: reply
  44. Euthyroid Graves’ disease with spurious hyperthyroidism: a diagnostic challenge
  45. A pilot plasma-ctDNA ring trial for the Cobas® EGFR Mutation Test in clinical diagnostic laboratories
  46. MS-based proteomics: a metrological sound and robust alternative for apolipoprotein E phenotyping in a multiplexed test
Downloaded on 9.12.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2018-0915/pdf
Scroll to top button